I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kowdley, K.
210
results:
Search for persons
X
Format
Online (210)
Mediatypes
Articles (Online) (150)
Bookchapter (Online) (4)
OpenAccess-fulltext (56)
Sorted by: Relevance
Sorted by: Year
?
1
Serum gamma-glutamyltransferase is a prognostic biomarker i..:
Gerussi, A.
;
Bernasconi, D.
;
O'donnell, S.E.
...
Digestive and Liver Disease. 52 (2020) - p. e4-e5 , 2020
Link:
https://doi.org/10.1016/..
?
2
SOF/VEL/VOX results in high SVR12 rates when administered f..:
Roberts, S.K.
;
Cooper, C.L.
;
Lawitz, E.
...
Journal of Hepatology. 66 (2017) 1 - p. S741 , 2017
Link:
https://doi.org/10.1016/..
?
3
Utilization of sofosbuvir/velpatasvir in genotype 2–6 HCV: ..:
Curry, M.
;
Bacon, B.
;
Dieterich, D.
...
Journal of Hepatology. 66 (2017) 1 - p. S58 , 2017
Link:
https://doi.org/10.1016/..
?
4
The safety and tolerability of SOF/VEL/VOX for 8 or 12 week..:
Manns, M.
;
Gane, E.J.
;
Willems, B.E.
...
Journal of Hepatology. 66 (2017) 1 - p. S722-S723 , 2017
Link:
https://doi.org/10.1016/..
?
5
Utilization of DAA therapies ledipasvir/sofosbuvir and sofo..:
Tsai, N.
;
Bacon, B.
;
Curry, M.
...
Journal of Hepatology. 66 (2017) 1 - p. S726 , 2017
Link:
https://doi.org/10.1016/..
?
6
Real-world treatment utilization and results in the renaiss..:
Flamm, S.
;
Bacon, B.
;
Curry, M.
...
Journal of Hepatology. 66 (2017) 1 - p. S740-S741 , 2017
Link:
https://doi.org/10.1016/..
?
7
Integrated analysis of controlled clinical trials evaluatin..:
Nguyen, M.H.
;
Chuang, W.-L.
;
Hassanein, T.
...
Journal of Hepatology. 66 (2017) 1 - p. S723 , 2017
Link:
https://doi.org/10.1016/..
?
8
Longitudinal changes in liver stiffness by magnetic resonan..:
Loomba, R.
;
Lawitz, E.
;
Ghalib, R.
...
Journal of Hepatology. 66 (2017) 1 - p. S671 , 2017
Link:
https://doi.org/10.1016/..
?
9
Real-world use of elbasvir/grazoprevir and outcomes in pati..:
Bacon, B.
;
Curry, M.
;
Dieterich, D.
...
Journal of Hepatology. 66 (2017) 1 - p. S295 , 2017
Link:
https://doi.org/10.1016/..
?
10
Comparison of clinical prediction rules for detection of ci..:
Brandman, D.
;
Boyle, M.
;
McPherson, S.
...
Journal of Hepatology. 66 (2017) 1 - p. S69-S70 , 2017
Link:
https://doi.org/10.1016/..
?
11
High efficacy is accompanied with substantial gains in pati..:
Younossi, Z.M.
;
Stepanova, M.
;
Jacobson, I.
...
Journal of Hepatology. 66 (2017) 1 - p. S114 , 2017
Link:
https://doi.org/10.1016/..
?
12
No impact of RASs on the high efficacy of SOF/VEL/VOX for 1..:
Sarrazin, C.
;
Cooper, C.L.
;
Manns, M.P.
...
Journal of Hepatology. 66 (2017) 1 - p. S299 , 2017
Link:
https://doi.org/10.1016/..
?
13
Elbasvir/Grazoprevir effectiveness in patients with Chronic..:
Younossi, Z.
;
Bacon, B.
;
Curry, M.
...
Journal of Hepatology. 66 (2017) 1 - p. S748-S749 , 2017
Link:
https://doi.org/10.1016/..
?
14
All-Oral Treatment with Daclatasvir Plus Sofosbuvir ± Ribav..:
Kowdley, K.
;
Angus, P.
;
Bernstein, D.
...
Journal of Hepatology. 64 (2016) 2 - p. S789-S790 , 2016
Link:
https://doi.org/10.1016/..
?
15
EFFECTIVENESS OF 12 OR 24 WEEK LDV/SOF AND 12 WEEK LDV/SOF+..:
Curry, M.
;
Bacon, B.
;
Dieterich, D.
...
Value in Health. 19 (2016) 3 - p. A312-A313 , 2016
Link:
https://doi.org/10.1016/..
1-15